(49) found that the levels of BM and circulating thrombopoietin (TPO) in MM patients at different stages of progression were higher than those in MGUS/SMM patients, and both endothelial cells (MGECs) from MGUS patients and endothelial cells (MMECs) from MM patients expressed TPO receptors. This evidence concerns the gene THPO and Miyoshi myopathy.